Mrs Kristen T Shoemake, LMSW | |
30826 Linder Rd, Denham Springs, LA 70726 | |
(225) 665-7878 | |
(225) 665-7856 |
Full Name | Mrs Kristen T Shoemake |
---|---|
Gender | Female |
Speciality | Case Manager/care Coordinator |
Location | 30826 Linder Rd, Denham Springs, Louisiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1346619202 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 11815 (Louisiana) | Secondary |
171M00000X | Case Manager/care Coordinator | (Louisiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Kristen T Shoemake, LMSW 30826 Linder Rd, Denham Springs, LA 70726-8507 Ph: (225) 665-7878 | Mrs Kristen T Shoemake, LMSW 30826 Linder Rd, Denham Springs, LA 70726 Ph: (225) 665-7878 |
News Archive
There are lessons to be learned from venoms. Scorpions, snakes, snails, frogs and other creatures are thought to produce tens or even hundreds of millions of distinct venoms. These venoms have been honed to strike specific targets in the body.
The WHO's Stop TB Department released data on Thursday at the 40th Union World Conference on Lung Health indicating that the number of new active TB cases worldwide rose from 9.27 million in 2007 to 9.4 million in 2008, Reuters reports. Experts, who were gathered for the conference in Cancun, Mexico, "called for more research funding to develop better diagnostic tests, vaccines and drugs for tuberculosis, which killed 1.8 million people around the world last year," according to the news service.
For patients on dialysis, taking medications to reduce levels of the mineral phosphorus in the blood may reduce the risk of death by 25 to 30 percent, reports a study in the Journal of the American Society of Nephrology (JASN).
Exactech, Inc., a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the company's Equinoxe® Platform Fracture Stem, the latest addition to the company's shoulder arthroplasty line.
› Verified 3 days ago